ANGELA NICOSON: Open Payments
NPI 1528692043 · BRAZIL, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$736 in 40 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $822 · 2025 $736
Food & beverage: $736
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $156 |
| Corcept Therapeutics | 4 | $92 |
| Novo Nordisk Inc | 4 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $52 |
| PFIZER INC. | 2 | $47 |
| Boston Scientific Corporation | 2 | $46 |
| Amgen Inc. | 2 | $33 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $29 |
Products named: JARDIANCE, Korlym, MOUNJARO, Kerendia, WATCHMAN FLX, OTEZLA, TRELEGY ELLIPTA, AIRSUPRA.
Industry payments across IN — which companies pay providers there.
